- Home
- VERV vs HIFS Comparison
VERV vs HIFS Comparison
Compare VERV & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- HIFS
- Stock Information
- Founded
- VERV 2018
- HIFS 1834
- Country
- VERV United States
- HIFS United States
- Employees
- VERV N/A
- HIFS N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- HIFS Major Banks
- Sector
- VERV Health Care
- HIFS Finance
- Exchange
- VERV Nasdaq
- HIFS Nasdaq
- Market Cap
- VERV 475.0M
- HIFS 518.9M
- IPO Year
- VERV 2021
- HIFS N/A
- Fundamental
- Price
- VERV $7.28
- HIFS $260.96
- Analyst Decision
- VERV Strong Buy
- HIFS
- Analyst Count
- VERV 4
- HIFS 0
- Target Price
- VERV $25.75
- HIFS N/A
- AVG Volume (30 Days)
- VERV 1.3M
- HIFS 12.7K
- Earning Date
- VERV 02-28-2025
- HIFS 04-11-2025
- Dividend Yield
- VERV N/A
- HIFS 0.97%
- EPS Growth
- VERV N/A
- HIFS 6.91
- EPS
- VERV N/A
- HIFS 12.85
- Revenue
- VERV $24,396,000.00
- HIFS $65,525,000.00
- Revenue This Year
- VERV $106.46
- HIFS N/A
- Revenue Next Year
- VERV N/A
- HIFS N/A
- P/E Ratio
- VERV N/A
- HIFS $20.31
- Revenue Growth
- VERV 219.91
- HIFS 3.21
- 52 Week Low
- VERV $4.31
- HIFS $160.00
- 52 Week High
- VERV $19.34
- HIFS $300.00
- Technical
- Relative Strength Index (RSI)
- VERV 47.08
- HIFS 47.82
- Support Level
- VERV $7.44
- HIFS $267.70
- Resistance Level
- VERV $9.31
- HIFS $281.61
- Average True Range (ATR)
- VERV 0.67
- HIFS 8.51
- MACD
- VERV -0.12
- HIFS 0.17
- Stochastic Oscillator
- VERV 14.01
- HIFS 48.31
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.
About HIFS Hingham Institution for Savings
Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.